BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 36237241)

  • 41. Meta-analysis of the effect and safety of recombinant human interferon α-2b combined with Baofukang suppository in the treatment of HPV infection.
    He C; Song C; Li M; Ma W; Sun S
    Am J Transl Res; 2022; 14(11):7632-7642. PubMed ID: 36505291
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ThinPrep cytologic test combined with HPV typing to evaluate the degree of cervical diseases and the relationship between HPV typing and the pathological results of patients with atypical squamous cells of undetermined significance: a diagnostic test.
    Wang L; Song Q; Liu Y; Ou Q
    Transl Cancer Res; 2022 Sep; 11(9):3277-3286. PubMed ID: 36237241
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical effect evaluation of high risk human papilloma virus E6/E7 mRNA in triaging women with atypical squamous cells of undetermined significance].
    Guo Z; Zhao DM; Zhang SK; Wu ZN; Sun XB; Jia MM; Chen Q; Guo LW; Chen PP; Zhang JG
    Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1094-1099. PubMed ID: 34695901
    [No Abstract]   [Full Text] [Related]  

  • 44. High-risk human papillomavirus and cervical intraepithelial neoplasia at time of atypical squamous cells of undetermined significance cytologic results in a population with human immunodeficiency virus.
    Kirby TO; Allen ME; Alvarez RD; Hoesley CJ; Huh WK
    J Low Genit Tract Dis; 2004 Oct; 8(4):298-303. PubMed ID: 15874876
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An efficient method that combines the ThinPrep cytologic test with E6/E7 mRNA testing for cervical cancer screening.
    Pan D; Zhang CQ; Liang QL; Hong XC
    Cancer Manag Res; 2019; 11():4773-4780. PubMed ID: 31213899
    [No Abstract]   [Full Text] [Related]  

  • 46. p16/Ki-67 dual-stained cytology used for triage in cervical cancer opportunistic screening.
    Han Q; Guo H; Geng L; Wang Y
    Chin J Cancer Res; 2020 Apr; 32(2):208-217. PubMed ID: 32410798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of 3D-CPA, HR-HPV, and TCT joint detection on cervical disease screening.
    Liang H; Fu M; Zhou J; Song L
    Oncol Lett; 2016 Aug; 12(2):887-892. PubMed ID: 27446364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study.
    Basu P; Malvi SG; Joshi S; Bhatla N; Muwonge R; Lucas E; Verma Y; Esmy PO; Poli URR; Shah A; Zomawia E; Pimple S; Jayant K; Hingmire S; Chiwate A; Divate U; Vashist S; Mishra G; Jadhav R; Siddiqi M; Sankaran S; Prabhu PR; Kannan TPRA; Varghese R; Shastri SS; Anantharaman D; Gheit T; Tommasino M; Sauvaget C; Pillai MR; Sankaranarayanan R
    Lancet Oncol; 2021 Nov; 22(11):1518-1529. PubMed ID: 34634254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Squamous intraepithelial lesions (SIL: LSIL, HSIL, ASCUS, ASC-H, LSIL-H) of Uterine Cervix and Bethesda System.
    Alrajjal A; Pansare V; Choudhury MSR; Khan MYA; Shidham VB
    Cytojournal; 2021; 18():16. PubMed ID: 34345247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcomes of primary radiotherapy with or without chemotherapy for advanced oral cavity squamous cell carcinoma: Systematic review.
    Membreno PV; Luttrell JB; Mamidala MP; Schwartz DL; Hayes DN; Gleysteen JP; Gillespie MB
    Head Neck; 2021 Oct; 43(10):3165-3176. PubMed ID: 34165221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of HPV subtypes not covered by the nine-valent vaccine in patients with CIN 2-3 and cervical squamous cell carcinoma.
    Ma MJ; Wang YN; Zhu JF; Wang XY; Jin YB; Liu XN; Wu SF; Yang YB
    Curr Probl Cancer; 2021 Dec; 45(6):100761. PubMed ID: 34154817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cellular Immunotherapy-Highlights from TCT 2021.
    Reshef R; Muranski P; Miller JS
    Transplant Cell Ther; 2021 Jul; 27(7):527-532. PubMed ID: 33915324
    [No Abstract]   [Full Text] [Related]  

  • 53. Diagnostic value of high-risk human papillomavirus viral load on cervical lesion assessment and ASCUS triage.
    Wang M; Hou B; Wang X; Han L; Shi Y; Zhang Y; Zhang L; Liu L; Jin F; Zhang Y
    Cancer Med; 2021 Apr; 10(7):2482-2488. PubMed ID: 33682355
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of DKK-1 gene methylation in exfoliated cells of cervical squamous cell carcinoma and its relationship with high risk HPV infection.
    He YH; Su RJ; Zheng J
    Arch Gynecol Obstet; 2021 Sep; 304(3):743-750. PubMed ID: 33547934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of low-grade cervical cytology in young women. Cohort study from Denmark.
    St-Martin G; Thamsborg LH; Andersen B; Christensen J; Ejersbo D; Jochumsen K; Johansen T; Larsen LG; Waldstrøm M; Lynge E
    Acta Oncol; 2021 Apr; 60(4):444-451. PubMed ID: 33030976
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.